In this paper, I empirically study the effect of IEEE’s IPR policy change in 2015 on standard related innovation. I construct a novel dataset of companies that have declared at least one patent as essential for an IEEE standard (the treatment group), and I then collect a sample of firms active...

Healthy organisms inevitably produce cancer cells, and vibrant patent systems inevitably let bad patents slip through. These patents are harnessed by entities that leverage the uncertainty and expense of litigation to extract licenses from technological practitioners. Postissuance patent review...

Using the pending Daiichi Sankyo case as a point of reference, this article examines whether EU exclusive competence under Article 207 TFEU requires the CJEU to interpret the patent provisions of the TRIPS Agreement and, if so, what are the implications for patent protection in the EU. It...